Valneva’s inactivated COVID-19 vaccine

Specialty vaccine company Valneva has developed a whole virus, inactivated, adjuvanted vaccine against COVID-19. It was developed and approved in Europe (conditional approval in the United Kingdom / standard approval in the European Union).


Valneva initiated additional clinical trials to potentially support future approval in further age groups and as a booster.

Read more here: